Case number 1:19-cv-01448
Bayer Intellectual Property GMBH et al v. Sunshine Lake Pharma Co., Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 5, 2019 | 9 | Notice (Other) (1) Docket Text: NOTICE of Dismissal with Prejudice by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc. (Fahnestock, Derek) |
| Aug 14, 2019 | 7 | Summons Returned Executed as to USA (2) Docket Text: SUMMONS Returned Executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. HEC Pharm USA Inc. served on 8/12/2019, answer due 10/11/2019. (Blumenfeld, Jack) |
| Aug 14, 2019 | 8 | Summons Returned Executed as to USA (2) Docket Text: SUMMONS Returned Executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. Sunshine Lake Pharma Co., Ltd. served on 8/12/2019, answer due 10/11/2019. (Blumenfeld, Jack) |
| Aug 7, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Timothy Belcher Dyk of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (TBD) after the case number on all documents filed. (nms) |
| Aug 1, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to HEC Pharm USA Inc. on 8/1/2019; Sunshine Lake Pharma Co., Ltd. on 8/1/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Aug 1, 2019 | 1 | Main Document (11) Docket Text: COMPLAINT - filed against HEC Pharm USA Inc., Sunshine Lake Pharma Co., Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2699554.) - filed by Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet) (lak) |
| Aug 1, 2019 | 1 | Exhibit A (14) |
| Aug 1, 2019 | 1 | Civil Cover Sheet (1) |
| Aug 1, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Aug 1, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/26/2019. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 12/26/2021. (lak) |
| Aug 1, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (lak) |
| Aug 1, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH filed by Bayer AG, Bayer Intellectual Property GMBH. (lak) |
| Aug 1, 2019 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (lak) |
| Aug 1, 2019 | 1 | Complaint* (1) |
